Concepedia

Author

Jeanne E. Anderson

Fred Hutch Cancer Center

Also Known As

J Anderson, J E Anderson, J. Anderson, J. E. ANDERSON, J. E. Anderson, J.E. Anderson, JEANNE E. ANDERSON, Jeanne Anderson, Jeanne E Anderson, Jeanne E. Anderson

144

Publications

5.2K

Citations

32

H-Index

92

Concepts

All Affiliations

Fred Hutch Cancer CenterUniversity of WashingtonBloodworks NorthwestThe University of Texas Health Science Center at San AntonioUniversity of Manitoba
JE

About

Jeanne E. Anderson is an author at Fred Hutch Cancer Center specializing in medicine, genetics, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

20

916

2

Health Sciences

4

4

346

3

Natural Sciences

3

3

46

4

Engineering

1

1

117

5

Humanities

1

1

16

Jeanne E. Anderson

×

55

Publications

4.9K

Citations

31

H-Index

YearCitations

Age and acute myeloid leukemia

Frederick R. Appelbaum, Holly Gundacker, David R. Head,

Blood

2006

1.3K

Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study.

Philippe Guardiola, Jeanne E. Anderson, Giuseppe Bandini,

PubMed

1999

277

Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.

Jeanne E. Anderson, Mark R. Litzow, F R Appelbaum,

Journal of Clinical Oncology

1993

243

A role for tumour necrosis factor‐α, Fas and Fas‐Ligand in marrow failure associated with myelodysplastic syndrome

Geoffrey M. Gersuk, C Beckham, Michael R. Loken,

British Journal of Haematology

1998

239

Phase I Study of Recombinant Human CD40 Ligand in Cancer Patients

Robert H. Vonderheide, Janice P. Dutcher, Jeanne E. Anderson,

Journal of Clinical Oncology

2001

224

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

H. Joachim Deeg, Howard M. Shulman, Jeanne E. Anderson,

Blood

2000

193

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

Jeanne E. Anderson, Kenneth J. Kopecky, Cheryl L. Willman,

Blood

2002

192

Stem Cell Transplantation for Secondary Acute Myeloid Leukemia: Evaluation of Transplantation as Initial Therapy or Following Induction Chemotherapy

Jeanne E. Anderson, Ted Gooley, Gary Schoch,

Blood

1997

158

Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score.

F R Appelbaum, Jeanne E. Anderson

PubMed

1998

148

Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS‐related acute myeloid leukaemia

Jeanne E. Anderson, Claudio Anasetti, Frederick R. Appelbaum,

British Journal of Haematology

1996

126

Page 1